Evommune (EVMN) Other Working Capital Changes (2024 - 2026)
Evommune's (EVMN) quarterly Other Working Capital Changes came in at -$193000.0 in Q1 2026, up 6.31% year-on-year from -$181543.4 in Q1 2025, and up 91.99% on a QoQ basis from -$2.4 million in Q4 2025.
Evommune (EVMN) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Other Working Capital Changes data on file, last reported at -$193000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 6.31% year-over-year to -$193000.0 in Q1 2026; TTM through Mar 2026 was -$3.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$3.0 million, down 290.12% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$193000.0, up from -$2.4 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for EVMN reached as high as $4.0 million in Q1 2025 and fell as low as $85000.0 in Q1 2026.
- Historically, Other Working Capital Changes has averaged $1.3 million across 3 years, with a median of $539000.0 in 2024.
- Across the five-year window, Other Working Capital Changes plunged 1092.57% in 2025 and climbed 6.31% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at -$202000.0 in 2024, then plunged by 1092.57% to -$2.4 million in 2025, then surged by 91.99% to -$193000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$193000.0 in Q1 2026, -$2.4 million in Q4 2025, and -$206000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Evommune | 381.48 Mn | 170.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85,000.00 |
| Mar 31, 2026 | 85,000.00 |
| Mar 31, 2026 | 85,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Mar 31, 2025 | 3.96 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 706,000.00 |
| Dec 31, 2024 | 706,000.00 |
| Dec 31, 2024 | 706,000.00 |